An overactive immune response to the Epstein-Barr virus, best known for causing mono, may help drive multiple sclerosis, a ...

Updated MS criteria may speed diagnosis but reshape clinical trials, increasing the need for better markers of progression ...

Overweight or obese people with early multiple sclerosis (MS) exhibit subtle gait changes, including taking wider steps.

A review study found resistance training, Pilates, and HIIT were linked to lower levels of the nerve damage biomarker NfL in ...

People with MS who closely follow a healthy diet had better disability scores over one year than those with lower adherence, ...

A noninvasive brain stimulation technique may help adults with multiple sclerosis walk farther and improve their balance.

Daily propionic acid supplements lowered levels of a nerve damage marker in people with MS, but clinical benefits remain ...

Columnist Ben Hofmeister has taken the liberty of adapting a few notorious quotes from the blockbuster film "Aliens" and applying them to MS.

Difficulties finding the right words during speech affect 25% of MS patients, and often occur alongside broader cognitive ...

Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.

AB Science has discontinued a large, late-stage trial testing its oral therapy masitinib in people with progressive multiple sclerosis. The trial was stopped due to a change in company priorities, not ...